Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 38K | Apr 30, 2024 | Direct | ||
Synaptogenix, Inc. | Director | Stock Option (Right to Buy) | 800 | Apr 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PMCB | PharmaCyte Biotech, Inc. | Apr 30, 2024 | 1 | $0 | 4 | Jul 17, 2024 | Director |
SNPX | Synaptogenix, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | Director |
PMCB | PharmaCyte Biotech, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Director |
OBLG | Oblong, Inc. | May 29, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |
SNPX | Synaptogenix, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
SNPX | Synaptogenix, Inc. | Dec 16, 2022 | 1 | -$23.7K | 4 | Dec 20, 2022 | Director |
SNPX | Synaptogenix, Inc. | Nov 15, 2022 | 1 | $0 | 4 | Nov 17, 2022 | Director |
PMCB | PharmaCyte Biotech, Inc. | Aug 15, 2022 | 0 | $0 | 3 | Aug 23, 2022 | Director |
SNPX | Synaptogenix, Inc. | Apr 5, 2022 | 1 | $0 | 4/A | Jun 23, 2022 | Director |
SNPX | Synaptogenix, Inc. | Jul 13, 2021 | 1 | $0 | 4 | Jul 15, 2021 | Director |
SNPX | Synaptogenix, Inc. | Jun 4, 2021 | 0 | $0 | 3/A | Jun 17, 2021 | Director |